Very stable 188Re-S4 chelates for labelling biomolecules: Preparation with highly concentrated perrhenate eluates

NuklearMedizin

Volumn 46, Issue 5, 2007, Pages 181-184

  Seifert, Sepp ^a   Jentschel, C ^a   Bergmann, R ^a   Pietzsch, H J ^a   Wunderlich, G ^b   Kotzerke, J ^b   Steinbach, J ^a  

^a INSTITUTE OF ION BEAM PHYSICS AND MATERIALS RESEARCH   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Radiolysis; Radiotherapy; Rhenium 188 complexes; Stability

Indexed keywords

ASCORBIC ACID; CHELATING AGENT; CROWN COMPOUND; EDETATE RE 188; EDETIC ACID; MERTIATIDE RE 188; MERTIATIDE TC 99M; PERRHENATE RE 188; RHENIUM 188; SUCCIMER; SUCCIMER RE 188; TRACER; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; LIGAND; PERRHENIC ACID; RADIOISOTOPE; RHENIUM;

ANIMAL EXPERIMENT; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; NONHUMAN; OXIDATION; RAT; THIN LAYER CHROMATOGRAPHY; CHEMICAL STRUCTURE; METHODOLOGY;

DRUG STABILITY; ISOTOPE LABELING; LIGANDS; MODELS, MOLECULAR; RADIOISOTOPES; RHENIUM;

EID: 35348995555     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1160/nukmed-0082     Document Type: Article

References (10)

1. Blower PJ, Lam ASK, O'Doherty MJ et al. Pentavalent rhenium-188 dimercaptosuccinic acid for targeted radiotherapy: synthesis and preliminary animal and human studies. Eur J Nucl Med 1998; 25: 613-621.
2. 3 as prosthetic groups for labeling amines and peptides: approaches with pre- and postconjugate labeling. Nucl Med Biol 1998; 25: 621-631.
3. 188Re tricarbonyl provides improved in vitro and in vivo stability to reoxidation. Nucl Med Commun 2004; 25: 731-736.
4. Heinrich T, Kraus W, Pietzsch H-J et al. A novel rhenium chelate system derived from dimercaptosuccinic acid for the selective labeling of biomolecules. Inorg Chem 2005; 44: 9930-9937.
5. Knapp FFjr, Beets AL, Guhlke S et al. Availability of rhenium-188 from the alumina based tungsten-188/rhenium-188 generator for preparation of rhenium-188 labeled radiopharmaceuticals for cancer treatment. Anticancer Res 1997; 17: 1783-1796.
6. 188Re at high labeling efficiency and specific radioactivity for tumor pretargeting. Appl Radiat Isot 2006; 64: 971-978.
7. + and synthesis of tailor-made bifunctional ligand systems. Bioconjugate Chem 2002; 13: 750-756.
8. 3/P ('4+1') coordination: relation of structure with antioxidation stability. Bioconjugate Chem 2005; 16: 634-643.
9. 188Re complexes under mild conditions. Appl Radiat Isot 2006; 64: 223-227.
10. 4 ligands derived from DMSA for labeling of biomolecules. Bioconjugate Chem 2006; 17: 1601-1608.